Rapid and reliable detection of antimicrobial peptide penetration into gram-negative bacteria based on fluorescence quenching

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 8, 2009, Pages 3501-3504

  Benincasa, Monica ^a   Pacor, Sabrina ^a   Gennaro, Renato ^a   Scocchi, Marco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BAC7 PEPTIDE[1-35]; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL; CELL PERMEABILIZATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG PENETRATION; FLOW CYTOMETRY; FLUORESCENCE; GRAM NEGATIVE BACTERIUM; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL;

ANTIMICROBIAL CATIONIC PEPTIDES; ESCHERICHIA COLI; FLOW CYTOMETRY; GRAM-NEGATIVE BACTERIA; MICROSCOPY, CONFOCAL; PEPTIDES, CYCLIC; POLYMYXIN B;

EID: 67749114474     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01620-08     Document Type: Article

References (25)

1. Benincasa, M., M. Scocchi, E. Podda, B. Skerlavaj, L. Dolzani, and R. Gennaro. 2004. Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates. Peptides 25:2055-2061.
2. Bergström, F., I. Mikhalyov, P. Hagglof, R. Wortmann, T. Ny, and L. B. Johansson. 2002. Dimers of dipyrrometheneboron difluoride (BODIPY) with light spectroscopic applications in chemistry and biology. J. Am. Chem. Soc. 124:196-204.
3. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
4. Cudic, M., and L. Otvos, Jr. 2002. Intracellular targets of antibacterial peptides. Curr. Drug Targets 3:101-106.
5. Daugelavicius, R., E. Bakiene, and D. H. Bamford. 2000. Stages of polymyxin B interaction with the Escherichia coli cell envelope. Antimicrob. Agents Chemother. 44:2969-2978.
6. Epand, R. M., and H. J. Vogel. 1999. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1462:11-28.
7. Gennaro, R., M. Zanetti, M. Benincasa, E. Podda, and M. Miani. 2002. Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr. Pharm. Des. 8:763-778.
8. Ghiselli, R., A. Giacometti, O. Cirioni, R. Circo, F. Mocchegiani, B. Skerlavaj, G. D'Amato, G. Scalise, M. Zanetti, and V. Saba. 2003. Neutralization of endotoxin in vitro and in vivo by Bac71-35, a proline-rich antibacterial peptide. Shock 19:577-581.
9. Gump, J. M., and S. F. Dowdy. 2007. TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol. Med. 13:443-448.
10. Hed, J., G. Hallden, S. G. Johansson, and P. Larsson. 1987. The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J. Immunol. Methods 101:119-125.
11. Henriques, S. T., J. Costa, and M. A. Castanho. 2005. Re-evaluating the role of strongly charged sequences in amphipathic cell-penetrating peptides: a fluorescence study using Pep-1. FEBS Lett. 579:4498-4502.
12. Henriques, S. T., M. N. Melo, and M. A. Castanho. 2006. Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem. J. 399:1-7.
13. Park, C. B., K. S. Yi, K. Matsuzaki, M. S. Kim, and S. C. Kim. 2000. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. USA 97:8245-8250.
14. Patel, L. N., J. L. Zaro, and W. C. Shen. 2007. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm. Res. 24: 1977-1992.
15. Patrzykat, A., C. L. Friedrich, L. Zhang, V. Mendoza, and R. E. Hancock. 2002. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother. 46:605-614.
16. Podda, E., M. Benincasa, S. Pacor, F. Micali, M. Mattiuzzo, R. Gennaro, and M. Scocchi. 2006. Dual mode of action of Bac7, a proline-rich antibacterial peptide. Biochim. Biophys. Acta 1760:1732-1740.
17. Powers, J. P., M. M. Martin, D. L. Goosney, and R. E. Hancock. 2006. The antimicrobial peptide polyphemusin localizes to the cytoplasm of Escherichia coli following treatment. Antimicrob. Agents Chemother. 50:1522-1524.
18. Sahalan, A. Z., and R. A. Dixon. 2008. Role of the cell envelope in the antibacterial activities of polymyxin B and polymyxin B nonapeptide against Escherichia coli. Int. J. Antimicrob. Agents 31:224-227.
19. Scocchi, M., M. Mattiuzzo, M. Benincasa, N. Antcheva, A. Tossi, and R. Gennaro. 2008. Investigating the mode of action of proline-rich antimicrobial peptides using a genetic approach: a tool to identify new bacterial targets amenable to the design of novel antibiotics. Methods Mol. Biol. 494:161-176.
20. Srimal, S., N. Surolia, S. Balasubramanian, and A. Surolia. 1996. Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A. Biochem. J. 315(Pt. 2):679-686.
21. Tsubery, H., I. Ofek, S. Cohen, and M. Fridkin. 2000. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide. Biochemistry 39:11837-11844.
22. Ulvatne, H., O. Samuelsen, H. H. Haukland, M. Kramer, and L. H. Vorland. 2004. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis. FEMS Microbiol. Lett. 237:377-384.
23. Van Amersfoort, E. S., and J. A. Van Strijp. 1994. Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes. Cytometry 17:294-301.
24. Walberg, M., P. Gaustad, and H. B. Steen. 1997. Rapid assessment of ceftazidime, ciprofloxacin, and gentamicin susceptibility in exponentiallygrowing E. coli cells by means of flow cytometry. Cytometry 27:169-178.
25. Zanetti, M. 2004. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75:39-48.